Effect of Elathy Chooranam and Vettiver thailam for Venpulli in Children

An open non randomized single arm single centric clinical trial to evaluate the effectiveness of Elathy Chooranam (Internal) and Vettiver thailam (External) for Venpulli (Vitiligo) in Children

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/04/041789

Enrollment

Registered

2022-04-11

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Elathy Chooranam (Internal) Vettiver Thailam (external): Dosage for Elathy Chooranam:1.5gm(verukadi) twice a day after food with honey Vettiver thailam-external use Duration:60 days Co

Eligibility

Inclusion criteria

Inclusion criteria: 1 Hypo pigmented patches with hyper pigmented border without any structural changes in any part of the body except lips,fingers and genital areas 2 Patient informant/Parent and patient are willing to sign the informed consent form and assent form stating that he/she will consciously stick to the treatment during 60 days but can opt out of the trial of his/her own conscious discretion 3 willing to cooperate for taking photographs whenever required with his/her consent

Exclusion criteria

Exclusion criteria: 1 Albinism 2 Leprosy 3 Tinea versicolor 4 Burn scar 5 Pityriasis alba 6 Chemical leucoderma 7 Any other serious illness

Design outcomes

Primary

Measure	Time frame
Efficacy of the trial drug measured using Vitiligo area Scoring Index(VASI)Timepoint: 60 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr M Meenakshi sundaram

National Institute of Siddha

mmssiddha@gmail.com9444214582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026